Nureca Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Virtually debt-free
Concerns
- Low capital efficiency (ROCE 3.3%)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
NURECA · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 63.24% | 63.24% | 63.24% | 63.78% | 64.06% | 64.30% |
| FII | 0.07% | 0.07% | 0.07% | 0.69% | 0.36% | 1.07% |
| DII | — | — | — | — | 0.04% | 0.04% |
| Public | 36.69% | 36.69% | 36.69% | 35.53% | 35.54% | 34.59% |
Latest News
All newsNureca promoters transfer shares, no holding change
*Nureca promoters transfer shares, no holding change* — Nureca Limited informs that there is no change in the aggregate shareholding of the promoter group following an inter se transfer of shares. The individual holdings within the group may have been adjusted, but total promoter stake remains unchanged. Such transfers are routine and do not impact ownership control. 📊 *STOCKS:* NURECA | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Promoter
Nureca discloses insider trading regulation update
*Nureca discloses regulatory filing under SEBI's PIT regulations.* This is a routine compliance update with no **financial impact** or operational change. Traders should note adherence to insider trading norms. No immediate price-moving event is indicated. 📊 *STOCKS:* NURECA | 🏢 *SECTOR:* CapitalMarkets | #Regulation #InsiderTrading
Nureca shares may see volatility on regulatory disclosure
*Nureca shares may see volatility on regulatory disclosure* The company filed a disclosure under Regulation 7(2) of SEBI's PIT Regulations, indicating routine compliance related to insider trading norms. No specific financial or operational update was provided. Such filings are typically procedural and do not reflect material business changes. 📊 *STOCKS:* NURECA | 🏢 *SECTOR:* CapitalMarkets | #REGULATION #InsiderTrading